Sweeping job cuts at GSK to fund £400m Cambridge campus

GSK is poised to slash its back office headcount to help fund a £400m mega-campus in Cambridge, in a move it hopes will bolster its drugs pipeline and stave off a looming patent cliff edge. In his first major strategy update as chief executive, Luke Miels unveiled plans for the new 300,000 square foot site…